Why isn’t blood glucose considered as, and monitored as, a vital sign? That’s the question this week’s guest is asking. Molly McElwee Malloy has big plans to change how hospitals and doctors are able to keep track of glucose. You may recognize Molly. She’s worked at Tandem Diabetes and kept us posted over the years…
[podcast src=”https://html5-player.libsyn.com/embed/episode/id/17577662/height/90/theme/custom/thumbnail/yes/direction/forward/render-playlist/no/custom-color/3e9ccc/” width=”100%” scrolling=”no” class=”podcast-class” frameborder=”0″ placement=”top” primary_content_url=”http://traffic.libsyn.com/diabetesconnections/Ep_346_Final_Tandem_2021_Malloy.mp3″ libsyn_item_id=”17577662″ height=”90″ theme=”custom” custom_color=”3e9ccc” player_use_thumbnail=”use_thumbnail” use_download_link=”use_download_link” download_link_text=”Download” /] It’s been a year since Tandem Diabetes Care released their Control IQ software, hybrid closed loop technology to help increase time in range. What have they learned about how people are using the system? Molly McElwee Malloy, Manager of…
[podcast src=”https://html5-player.libsyn.com/embed/episode/id/12555608/height/90/theme/custom/thumbnail/yes/direction/forward/render-playlist/no/custom-color/445599/” width=”100%” height=”90″ scrolling=”no” class=”podcast-class” frameborder=”0″ placement=”top” use_download_link=”use_download_link” download_link_text=”Download” primary_content_url=”http://traffic.libsyn.com/diabetesconnections/Ep_268_Final_Control_IQ_Molly.mp3″ theme=”custom” custom_color=”445599″ libsyn_item_id=”12555608″ /] Tandem’s Control-IQ system was approved by the US FDA in mid-December. In this episode, Stacey talks to Molly McElwey Malloy, Tandem’s clinical outcomes manager with behavioral sciences. Check out Stacey’s new book: The World’s Worst Diabetes Mom! Control-IQ technology is…
Tandem answers your questions about the newly approved and not- yet-released Basal IQ system. The FDA took a lot of people by surprise by approving it with the Dexcom G6. We talk to Tandem’s Molly McElwee Malloy about how the system works, when it’ll be available to T:Slim users and what’s next for the company.…
Find out the latest from Tandem, makers of the T:slim insulin pump. Spokesperson Molly McElwee Malloy shares how close they are to a hybrid closed loop, which they’re calling Control IQ, and other products. Malloy. diagnosed with type 1 as a young adult, was in one of the first artificial pancreas trials back in 2006…
The Type Zero Technologies artificial pancreas project is one of the many racing to market. Their technology comes from years of research, still ongoing, at the University of Virginia. This summer, they announced a new partnership with Tandem. Molly McElwee Malloy, who has type 1 herself, is the head of patient engagement for Type Zero. She talks…